Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study
Bernard Combe, Bhaskar Dasgupta, Ingrid Louw, Sarvajeet Pal, Jürgen Wollenhaupt, Cristiano A F Zerbini, Andre D Beaulieu, Hendrik Schulze-Koops, Patrick Durez, Ruji Yao, Nathan Vastesaeger, Haoling H Weng, on Behalf of the GO-MORE Investigators
Annals of the Rheumatic Diseases Aug 2014, 73 (8) 1477-1486; DOI: 10.1136/annrheumdis-2013-203229